Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

675 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC. Urban P, et al. Among authors: capodanno d. Eur Heart J. 2019 Aug 14;40(31):2632-2653. doi: 10.1093/eurheartj/ehz372. Eur Heart J. 2019. PMID: 31116395 Free PMC article.
Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry.
Tamburino C, Di Salvo ME, Capodanno D, Capranzano P, Parisi R, Mirabella F, Scardaci F, Ussia G, Galassi AR, Fiscella D, Mehran R, Dangas G. Tamburino C, et al. Among authors: capodanno d. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):243-8. doi: 10.1002/ccd.21750. Catheter Cardiovasc Interv. 2009. PMID: 19156896
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry.
Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, Maresta A, Barlocco F, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Patti A, De Servi S. Tamburino C, et al. Among authors: capodanno d. Eur Heart J. 2009 May;30(10):1171-9. doi: 10.1093/eurheartj/ehp052. Epub 2009 Mar 10. Eur Heart J. 2009. PMID: 19276194
First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
Tamburino C, La Manna A, Di Salvo ME, Sacchetta G, Capodanno D, Mehran R, Dangas G, Corcos T, Prati F. Tamburino C, et al. Among authors: capodanno d. JACC Cardiovasc Interv. 2009 Mar;2(3):197-204. doi: 10.1016/j.jcin.2008.12.006. JACC Cardiovasc Interv. 2009. PMID: 19463426 Free article. Clinical Trial.
Platelet thrombin receptor antagonism and atherothrombosis.
Angiolillo DJ, Capodanno D, Goto S. Angiolillo DJ, et al. Among authors: capodanno d. Eur Heart J. 2010 Jan;31(1):17-28. doi: 10.1093/eurheartj/ehp504. Epub 2009 Nov 30. Eur Heart J. 2010. PMID: 19948715 Free PMC article. Review.
Impact of race and gender on antithrombotic therapy.
Capodanno D, Angiolillo DJ. Capodanno D, et al. Thromb Haemost. 2010 Sep;104(3):471-84. doi: 10.1160/TH10-04-0232. Epub 2010 Jul 20. Thromb Haemost. 2010. PMID: 20664898 Review.
675 results